project id: TCGA-CESC; case submitter id: TCGA-JW-A5VK; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.94; concentration: 0.16; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.84; rna integrity number: 9.3; age at index: 43; days to birth: -15965; ethnicity: not hispanic or latino; gender: female; race: black or african american; vital status: Alive; year of birth: 1969; age at diagnosis: 15965; ajcc pathologic m: MX; ajcc pathologic n: NX; ajcc pathologic t: T1b2; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 623.0; figo stage: Stage IB2; icd 10 code: C53.9; last known disease status: not reported; morphology: 8052/3; primary diagnosis: Papillary squamous cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cervix uteri; synchronous malignancy: No; tissue or organ of origin: Cervix uteri; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 0.0547945205479452; pack years smoked: 1.0; is ffpe: false; composition: Not Reported; days to collection: 219; days to sample procurement: 0; initial weight: 80.0; portion submitter id: TCGA-JW-A5VK-01A-11; percent lymphocyte infiltration: 40.0; percent monocyte infiltration: 20.0; percent necrosis: 5.0; percent neutrophil infiltration: 20.0; percent normal cells: 0.0; percent stromal cells: 5.0; percent tumor cells: 90.0; percent tumor nuclei: 90.0;